Law360, New York (May 20, 2009, 12:00 AM EDT) -- New details have emerged in the Seroquel debacle, with plaintiffs' lawyers reportedly releasing a slew of documents they say prove AstraZeneca Pharmaceuticals LP executives knew the blockbuster anti-psychotic medication could lead to weight gain and diabetes but agreed to promote it for off-label uses in children and the elderly anyway.
The documents – which were not yet available in court dockets – were handed over by the company during pretrial proceedings in thousands of lawsuits that have been consolidated in a multidistrict litigation in the U.S....
Seroquel Docs Implicate AstraZeneca Execs: Attys
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
